Anthem to cover female libido drug Addyi; Cigna and Aetna on the fence

Health insurers are on the fence about covering Sprout Pharmaceutical's new pill, Addyi, which treats low libido in women, reports the Indianapolis Business Journal. Anthem, for instance, said it will cover the pill in many cases, while Cigna and Aetna still are evaluating their policies. Express Scripts and CVS Health will continue to work on their policies as well. This may be troublesome for Sprout, since getting coverage from insurers is vital--the company only just gained approval for the pill from the Food and Drug Administration after having been previously rejected in 2010 and 2013. If insurers forgo covering the pill, women may have to dish out some $400 a month to see if the drug will work. Considering the pill's potential side effects, which involve fainting, insurers will focus on the safety and effectiveness of the treatment. Article


Suggested Articles

Humana filed suit Friday against more than a dozen generic drugmakers alleging the companies engaged in price fixing.

Medicare Advantage open enrollment kicked off last week, and insurers are taking new approaches to marketing a slate of supplemental benefit options. 

Centene announced another five states have approved its pending $17B merger with WellCare, bringing total number of approvals to 24.